Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arcadia Biosciences, Inc. | Chief Executive Officer | Common Stock | 2.12K | $4.37K | $2.06 | Aug 1, 2024 | Direct |
Arcadia Biosciences, Inc. | Chief Executive Officer | Stock Option (Right to Buy) | 25.5K | Aug 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RKDA | Arcadia Biosciences, Inc. | Aug 19, 2024 | 1 | $0 | 4 | Aug 21, 2024 | Chief Executive Officer |
RKDA | Arcadia Biosciences, Inc. | Aug 1, 2024 | 1 | $1.44K | 4 | Aug 20, 2024 | Chief Executive Officer |
RKDA | Arcadia Biosciences, Inc. | Feb 1, 2024 | 1 | $1.44K | 4 | Feb 5, 2024 | Chief Financial Officer |
RKDA | Arcadia Biosciences, Inc. | Aug 4, 2023 | 1 | $2.38K | 4 | Aug 7, 2023 | Chief Financial Officer |
RKDA | Arcadia Biosciences, Inc. | Apr 4, 2023 | 1 | $0 | 4 | Apr 28, 2023 | Chief Financial Officer |
RKDA | Arcadia Biosciences, Inc. | Feb 1, 2023 | 1 | $161 | 4 | Feb 2, 2023 | Chief Financial Officer |
RKDA | Arcadia Biosciences, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Chief Financial Officer |
RKDA | Arcadia Biosciences, Inc. | Jan 3, 2023 | 0 | $0 | 3 | Jan 5, 2023 | Chief Financial Officer |